Skip to content

Clinical trials

Phase 2 Multiple Sclerosis trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Phase: Phase 2 Country / region: Czechia Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20073
20081
20093
20104
20112
20121
20134
20161
20172
20181
20212
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated7
Active, not recruiting2
Recruiting2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen7
Novartis Pharmaceuticals4
Actelion2
EMD Serono2
GeNeuro SA2
GlaxoSmithKline2
Avanir Pharmaceuticals1
Avigen1
Celgene1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis29
Multiple Sclerosis, Relapsing-Remitting11
Multiple Sclerosis, Chronic Progressive2
Muscle Spasticity2
Amyotrophic Lateral Sclerosis1
Autoimmune Diseases1
Demyelinating Diseases1
Immune System Diseases1
Major Depressive Disorder1
Nervous System Diseases1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.